Compliance Radar
Who was sanctioned, and for what?
Fines, court rulings and incidents from Europe and North America: 718 cases from 32 jurisdictions, each with an official source and checked against that source before publication. Filter by country, area of law and sector. Click a chart to drill down one level.
Click a bar to drill down one level.
Where?
by regionAll jurisdictions
What for?
by area of lawAll areas of law
Who?
by company- ExxonMobil Chemical Limited 2 cases 8 % · €513,011
- AFCO (Tochtergesellschaft der Zep Inc.) 1 case 4 % · €157,452
- Alkaloids of Australia, Alkaloids Corporation, Boehringer, Linnea, Transo-Pharm (C2 PHARMA Kronzeuge) 1 case 4 % · €13.4m
- Colorcon Limited 1 case 4 % · €176,590
- Dompé U.S. Inc. 1 case 4 % · €27.5m
- Estee Lauder Cosmetics Ltd. 1 case 4 % · €463,765
- EyePoint Pharmaceuticals, Inc. 1 case 4 % · €4.08m
- Gilead Sciences, Inc. 1 case 4 % · €177.8m
- Guangxi Kelun Pharmaceutical Co., Ltd. 1 case 4 % ·
- Henkel AG & Co. KGaA 1 case 4 % ·
- 13 more13 cases
When?
per quarter, by date of decision| Period | Cases | Total |
|---|---|---|
| Q3 2023 | 0 | — |
| Q4 2023 | 0 | — |
| Q1 2024 | 0 | — |
| Q2 2024 | 0 | — |
| Q3 2024 | 0 | — |
| Q4 2024 | 1 | €1.8m |
| Q1 2025 | 0 | — |
| Q2 2025 | 0 | — |
| Q3 2025 | 0 | — |
| Q4 2025 | 0 | — |
| Q1 2026 | 0 | — |
| Q2 2026 | 0 | — |
| Q3 2026 | 0 | — |
1 case
22 Nov 2024 Viatris Inc.Viatris: 1.5 million GBP – key staff replaced despite hold-separate order €1.8m
During the review of the sale of the European rights to the hormone products Duphaston and Femoston to Theramex, an Initial Enforcement Order was in force. Viatris replaced members of the UK management without the consent of the Competition and Markets Authority (CMA) and subsequently failed to report the breach; the CMA imposed 1.5 million GBP.
During a merger review, staffing decisions in the target business also require consent – and breaches must be reported immediately.
Standstill and interim obligations in merger proceedings (management, HR)
- Authority / court
- Competition and Markets Authority (CMA)
- Area of law
- Competition law · Merger control
- Legal basis
- Enterprise Act 2002, s. 72(2) (Initial Enforcement Order), s. 94A
- Action
- Fine
- Status of proceedings
- unknown
- Sector
- Chemicals and pharmaceuticals
- Employees
- 10,000 or more
Original amount 1,500,000 GBP, converted at the ECB reference rate of 22 Nov 2024.
- CMA: Viatris fined £1.5m for failure to comply with CMA order (22.11.2024) Press release of an authority
Checked against the official source on 25 Sep 2026 · Direct link